Delivery Order SPE2DB20D1109-SPE2DB22FP03M
Award Date 4/18/22
Potential Completion Date 4/19/22
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,068.22 delivery order is for the pharmaceutical product Feraheme (ferumoxytol injection) 510 mg/17 mL vial. The contract has a firm fixed price and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Feraheme (ferumoxytol) 510 mg/17 mL vials to the Defense Logistics Agency (DLA). The $3,913.10 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 23, 2021, with an ultimate completion date of August 24, 2021. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,119.99 Firm Fixed Price delivery order is for the supply of Feraheme 510 mg/17 ml vials, a pharmaceutical product used for the treatment of iron deficiency anemia. The award is a child contract under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $3,764.40, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 27, 2022, with a completion date of January 28, 2022. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
- The U.S. government has awarded a Firm Fixed Price Delivery Order contract, valued at $1,548.97, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Feraheme 510 mg/17 ml vial medical supplies. This order is placed against an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds as the prime contractor with the Defense Logistics Agency (DLA) Troop Support Medical to deliver a comprehensive range...
- This federal contract award, valued at $2,895.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the pharmaceutical product Feraheme 510 mg/17 ml vial, with a performance period extending through May 7, 2025. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Feraheme 510 mg/17 ml vial, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The $14,952.56 contract was awarded on January 17, 2023 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of January 18, 2023 and is a firm fixed price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Feraheme 510 mg/17 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $54,916.16 and a performance period extending to July 7, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme 510 mg/17 ml vials. The contract has a firm fixed-price structure and a ceiling value of $9,635.91. It was awarded on November 4, 2024, with an ultimate completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,830.51 order is for the drug Feraheme (510 mg/17 ml vial) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and...